Commonwealth Bank of Australia’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-43
| Closed | -$3K | – | 48 |
|
|
2019
Q2 | $3K | Hold |
43
| – | – | ﹤0.01% | 1128 |
|
|
2019
Q1 | $4K | Hold |
43
| – | – | ﹤0.01% | 1116 |
|
|
2018
Q4 | $3K | Buy |
43
+23
| +115% | +$1.61K | ﹤0.01% | 1125 |
|
|
2018
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 1152 |
|
|
2018
Q2 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 833 |
|
|
2017
Q1 | – | Sell |
-600
| Closed | -$22K | – | 885 |
|
|
2016
Q4 | $22K | Buy |
600
+300
| +100% | +$11K | ﹤0.01% | 817 |
|
|
2016
Q3 | $20K | Hold |
300
| – | – | ﹤0.01% | 821 |
|
|
2016
Q2 | $17K | Hold |
300
| – | – | ﹤0.01% | 787 |
|
|
2016
Q1 | $19K | Buy |
300
+200
| +200% | +$12.7K | ﹤0.01% | 798 |
|
|
2015
Q4 | $9K | Buy |
+100
| New | +$9K | ﹤0.01% | 830 |
|
|
2014
Q2 | – | Sell |
-6,077
| Closed | -$408K | – | 790 |
|
|
2014
Q1 | $408K | Buy |
6,077
+177
| +3% | +$11.9K | ﹤0.01% | 1086 |
|
|
2013
Q4 | $379K | Buy |
+5,900
| New | +$379K | ﹤0.01% | 1087 |
|